Početna › Autoimune bolesti › Florida
Kliničke studije za Autoimune bolesti u državi Florida
20 studija za Autoimune bolesti traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
- Jacksonville6 studija
- Miami6 studija
- Orlando4 studija
- Tampa4 studija
- St. Petersburg3 studija
- Gainesville3 studija
Službeni tekst studije (engleski)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Clinical Res Of W Florida, Clearwater
- Clinical Research of West Florida Inc, Tampa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07621809Secukinumab Open Label Roll-over Extension Protocol
- Rheumatology Associates of South Florida, Boca Raton
- FL Medical Clinic Orlando Health, Zephyrhills
U tijeku regrutacijaFaza 4
Od 6 do 100 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT04638647A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Orlando
- Jade Clinical Site, Pembroke Pines
U tijeku regrutacijaFaza 2
Od 18 do 60 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07541287Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Miami Clinical Research, Miami
- GCP Clinical Research, Tampa
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT07513181RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Mayo Clinic Florida - Accepting Adult Patients, Jacksonville
- Johns Hopkins All Children's Hospital - Accepting Juvenile Patients, St. Petersburg
U tijeku regrutacijaFaza 2/3
Od 6 do 75 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT06154252A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Mayo Clinic, Jacksonville
U tijeku regrutacijaFaza 1
Od 18 do 74 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT07085104PS-002 for the Treatment of IgA Nephropathy in Adults
- University of Miami Hospital, Miami
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07182227A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Gainesville
- GSK Investigational Site, Naples
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06572384RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Mayo Clinic, Jacksonville
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 26. kol 2026. · NCT06121297RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Florida, Jacksonville
U tijeku regrutacijaFaza 2/3
Od 18 do 75 godina · Oba spola · Ažurirano 17. kol 2026. · NCT06328777Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Nephrology Associates Of Central FL, Orlando
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 17. kol 2026. · NCT06858319RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Mayo Clinic Florida, Jacksonville
U tijeku regrutacijaFaza 1/2
Od 18 do 70 godina · Oba spola · Ažurirano 13. kol 2026. · NCT06359041A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- University of Southern Florida, St. Petersburg
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT06056297Study of BHV-1300 in Graves' Disease
- Site-100, Miami
U tijeku regrutacijaFaza 1
Od 18 do 65 godina · Oba spola · Ažurirano 31. srp 2026. · NCT06980649Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1006, Clearwater
- Site Number - 1037, Ormond Beach
- Site Number - 1002, Port Charlotte
- i još 2
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 30. srp 2026. · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- University of Miami, Miami
U tijeku regrutacijaFaza 2/3
Od 18 do 75 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06193889A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Florida Shands Medical Center, Gainesville
- Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
- University of Miami (peds), Miami
- i još 6
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 6. srp 2026. · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- University of South Florida - Carol and Frank Morsani Center of Advanced Healthcare, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. velj 2026. · NCT06626919Rheumatology Diet Study
- UCF Health Clinics, Orlando
U tijeku regrutacijaOpažajna studija
Od 18 do 65 godina · Oba spola · Ažurirano 6. pro 2024. · NCT06339957Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.